Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
methylcobalamin + pyridoxine + folic acid
- Development stage
- Unknown
- Lead developer
- Invenex
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
METH-12 is an oral combination supplement developed by Invenex Pharma, containing methylcobalamin (1500 mcg), pyridoxine hydrochloride (20 mg), and folic acid (5 mg). This formulation is designed to address nutritional deficiencies and support neurological health, particularly in conditions like peripheral neuropathy and hyperhomocysteinemia. Methylcobalamin, the active form of Vitamin B12, serves as a cofactor for methionine synthase, which is critical for DNA synthesis and the maintenance of the myelin sheath. Pyridoxine (Vitamin B6) acts as a coenzyme in numerous enzymatic reactions, including neurotransmitter synthesis and amino acid metabolism. Folic acid (Vitamin B9) is essential for the production and maintenance of new cells. Together, these components work synergistically to lower homocysteine levels, thereby reducing cardiovascular risk and promoting nerve regeneration.
- Brand names
- METH-12METH12METH 12
- Other names
- Methylcobalamin 1500mcg + Pyridoxine HCL 20mg + Folic acid 5mg
02
Targets
MTR (Methionine synthase)CBS (Cystathionine beta-synthase)MTHFR (Methylenetetrahydrofolate reductase)
Beyond the preview
Go deeper on methylcobalamin + pyridoxine + folic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on methylcobalamin + pyridoxine + folic acid.